martes, 14 de febrero de 2017

NIAID Treatment Study for Allergic Eczema

NIAID Treatment Study for Allergic Eczema
Allergic eczema (a.k.a. “atopic dermatitis”) is much more common today than it was 30 years ago, affecting 10-20% of children around the world. Treatment cannot cure atopic dermatitis, but it can control it and NIAID researchers are testing a new approach to therapy.
You may be eligible to participate in the study if:
  • You are at least 7 years old
  • Your doctor has diagnosed you with atopic dermatitis
  • Your rash is located on your forearm or elbow
  • You are willing to make at least 4 visits to the NIH Clinical Center in Bethesda, Maryland, during the year-long study.
Read more about the clinical trial of Roseomonas Treatment Efficacy in Atopic Dermatitis (study ID NCT03018275)

No hay comentarios:

Publicar un comentario